An international team of researchers has discovered a pan-variant and extremely effective neutralizing antibody called "S2X324" that can counteract Omicron variations. According to the study published in the journal Science, none of the tested Omicron variations significantly impacted its neutralizing potency.

The researchers hypothesized that combining this antibody with others in a cocktail could lessen the virus′s likelihood of developing resistance to antibody treatment.

The group examined several features of how the immune system responded to prior iterations of the SARS-CoV-2 spike antigen, also known as the immune-provoking protein. They noted that the considerably diminished antibody neutralizing capacity against these variations, particularly in those who have not received booster doses, is caused by changes in two of the virus′s primary antibody targets.

The Omicron versions, which first surfaced around the end of 2021, differ genetically significantly from the original SARS-CoV-2. They have been able to avoid antibodies produced by the initial set of vaccines, from a history of infection, or both of those two immune-system training events thanks to the numerous mutations in their infection machinery.

The neutralizing antibodies against these variations were also created in the mucus lining the inside of the noses of those who experienced a breakthrough infection following vaccination. The nasal mucosa of those who simply got the vaccine, however, did not produce any antibodies.

As the nose is typically the site where the virus enters the body, experts indicated that this finding supports attempts to develop and study next-generation Covid-19 vaccines that might be administered intranasally.

(Source: https://www.tribuneindia.com/news/health/scientists-identify-ultra-potent-antibody-that-can-offset-all-omicron-variants-446246)